Abstract：Objective To explore clinical efficacy of Hydrocortisone combined with Ulinastatin in treatment of septic shock. Methods From September 2015 to September 2018, 80 cases with septic shock admitted to Guangxi Zhuang Autonomous Region Liuzhou People′s Hospital were selected. According to the random number table method, they were divided into the control group (40 cases) and the observasion group (40 cases). Both groups were given conventional treatment, the control group was given Hydrocortisone on the basis of conventional treatment, and the observasion group was treated with Hydrocortisone combined with Ulinastatin. The two groups were continuously treated for 2 weeks. Clinical efficacy was evaluated after treatment. The mechanical ventilation time, hospitalization time were compared between the two groups. The acute physiology and chronic health evaluation Ⅱ (APACHEⅡ) score, systolic blood pressure (SBP), white blood cell count (WBC), levels of serum C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and procalcitonin (PCT) of the two groups before and after treatment were compared. The occurrence of adverse reactions and 28-day mortality during the treatment of the two groups was recorded. Results The total clinical effective rate of the observasion group was significantly higher than that of the control group, the difference was statistically significant (P < 0.05). The mechanical ventilation time and hospitalization time of the observasion group were significantly shorter than those of the control group, the differences were statistically significant (all P < 0.05). The APACHEⅡ score, WBC of the observasion group were significantly shorter than those of the control group, SBP of the observasion group was significantly higher than that of the control group, the differences were statistically significant (all P < 0.05). The level of serum CRP, TNF-α and PCT of the observasion group were significantly lower than those of the control group, the differences were statistically significant (all P < 0.05). The 28-day mortality of the observasion group was lower than that of the control group, the difference was statistically significant (P < 0.05). There was no obvious adverse reactions in the course of treatment in both groups. Conclusion Hydrocortisone combined with Ulinastatin is significantly effective in treatment of septic shock, which can significantly alleviate the illness, improve the body′s level of inflammation and reduce mortality.
2019, Vol. 16 
京公网安备 11010502046598号